38857206|t|Perturbations of Telmisartan Alone and in Combination with Ranolazineor Dapagliflozin on the Amplitude and Gating of Voltage-gated Na + Current in Neuroblastoma Neuronal Cells.
38857206|a|A recent study investigated the correlation between telmisartan (TEL) exposure and Alzheimer's disease (AD) risk among African Americans (AAs) and European Americans. Their findings indicated that moderate-to-high TEL exposure was linked to a decreased incidence of AD among AAs. These results suggest a potential association between TEL and a reduced risk of AD specifically within the AA population. Here, we investigated the effects of TEL, either alone or in combination with ranolazine (Ran) or dapagliflozin (Dapa), on voltage-gated Na + currents ( INa ) in Neuro-2a cells. TEL, primarily used for treating hypertension and cardiovascular disorders, showed a stimulatory effect on INa , while Ran and Dapa reversed this stimulation. In Neuro-2a cells, we demonstrated that with exposure to TEL, the transient ( INa(T) ) and late ( INa(L) ) components of INa were differentially stimulated with effective EC 50 's of 16.9 and 3.1 muM, respectively. The research implies that TEL's impact on INa might be associated with enhanced neuronal excitability. This study highlights the complex interplay between TEL, Ran, and Dapa on INa and their potential implications for AD, emphasizing the need for further investigation to understand the mechanisms involved.
38857206	17	28	Telmisartan	Chemical	MESH:D000077333
38857206	59	71	Ranolazineor	Chemical	-
38857206	72	85	Dapagliflozin	Chemical	MESH:C529054
38857206	131	135	Na +	Chemical	MESH:D012964
38857206	147	160	Neuroblastoma	Disease	MESH:D009447
38857206	229	240	telmisartan	Chemical	MESH:D000077333
38857206	242	245	TEL	Chemical	MESH:D000077333
38857206	260	279	Alzheimer's disease	Disease	MESH:D000544
38857206	281	283	AD	Disease	MESH:D000544
38857206	391	394	TEL	Chemical	MESH:D000077333
38857206	443	445	AD	Disease	MESH:D000544
38857206	511	514	TEL	Chemical	MESH:D000077333
38857206	537	539	AD	Disease	MESH:D000544
38857206	616	619	TEL	Chemical	MESH:D000077333
38857206	657	667	ranolazine	Chemical	MESH:D000069458
38857206	669	672	Ran	Chemical	MESH:D000069458
38857206	677	690	dapagliflozin	Chemical	MESH:C529054
38857206	692	696	Dapa	Chemical	MESH:C529054
38857206	716	720	Na +	Chemical	MESH:D012964
38857206	741	749	Neuro-2a	CellLine	CVCL:0470
38857206	757	760	TEL	Chemical	MESH:D000077333
38857206	790	802	hypertension	Disease	MESH:D006973
38857206	807	831	cardiovascular disorders	Disease	MESH:D002318
38857206	876	879	Ran	Chemical	MESH:D000069458
38857206	884	888	Dapa	Chemical	MESH:C529054
38857206	919	927	Neuro-2a	CellLine	CVCL:0470
38857206	973	976	TEL	Chemical	MESH:D000077333
38857206	1157	1160	TEL	Chemical	MESH:D000077333
38857206	1286	1289	TEL	Chemical	MESH:D000077333
38857206	1291	1294	Ran	Chemical	MESH:D000069458
38857206	1300	1304	Dapa	Chemical	MESH:C529054
38857206	1349	1351	AD	Disease	MESH:D000544
38857206	Negative_Correlation	MESH:D000069458	MESH:D002318
38857206	Cotreatment	MESH:D000069458	MESH:D000077333
38857206	Negative_Correlation	MESH:C529054	MESH:D006973
38857206	Negative_Correlation	MESH:C529054	MESH:D002318
38857206	Negative_Correlation	MESH:D000077333	MESH:D006973
38857206	Negative_Correlation	MESH:C529054	MESH:D000077333
38857206	Negative_Correlation	MESH:D000077333	MESH:D000544
38857206	Association	MESH:D000077333	MESH:D012964
38857206	Association	MESH:C529054	MESH:D012964
38857206	Negative_Correlation	MESH:D000077333	MESH:D002318
38857206	Comparison	MESH:C529054	MESH:D000069458
38857206	Association	MESH:D012964	MESH:D009447

